Brief: Crescita Therapeutics Q4 Net Loss Per Share $0.59

Crescita Therapeutics

28/03/2018 12:42

March 28 (Reuters) - Crescita Therapeutics Inc  CTX.TO :
    * CRESCITA THERAPEUTICS REPORTS 2017 FOURTH QUARTER AND YEAR
END
RESULTS
    * QTRLY NET LOSS PER SHARE FROM CONTINUING OPERATIONS $0.59
    * QTRLY REVENUE C$2.4 MILLION VERSUS C$2.2 MILLION
    * CASH AND CASH EQUIVALENTS WERE $7.0 MILLION AS AT DECEMBER
31,
2017 COMPARED TO $9.8 MILLION AS AT DECEMBER 31, 2016

Source text for Eikon:  ID:nCNWftSpna 
Further company coverage:  CTX.TO 

 ((Reuters.Briefs@thomsonreuters.com;))